PSFE vs CLOV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

PSFE

48.3
AI Score
VS
PSFE Wins

CLOV

39.6
AI Score

Investment Advisor Scores

PSFE

48score
Recommendation
HOLD

CLOV

40score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric PSFE CLOV Winner
Forward P/E 3.2971 81.9672 PSFE
PEG Ratio 0 0 Tie
Revenue Growth 10.4% 55.6% CLOV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 48.3/100 39.6/100 PSFE
Profit Margin -11.4% -0.7% CLOV
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL PSFE

Relative Price Performance (Last 90 Days)

PSFE 1M: -11.4% · 3M: -6.3% CLOV 1M: -8.8% · 3M: +15.3%

Current Technical Phase

PSFE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 44

RSI (14): 43.6 · Price: $6.87

CLOV

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $4.15

Fundamentals Snapshot

Metric PSFE CLOV
Market Cap
Forward P/E 3.1 27.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.6%
Gross Margin 0.6% 0.2%
Operating Margin 0.0% 0.0%
EPS -3.94 -0.05
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PSFE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.